Five-Year Optical Coherence Tomography Follow-Up of an Everolimus-Eluting Bioresorbable Vascular Scaffold

Αντώνιος Καρανάσος; Cihan Şimşek; Patrick W. Serruys; Jürgen Ligthart; Karen Witberg; Robert‐Jan van Geuns; George Sianos; Felix Zijlstra; Evelyn Regar

doi:10.1161/circulationaha.112.110122

Related publications

Article2013

Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment

Héctor M. García‐García, Carl Schultz, Eric Duckers, Evelyn Regar, Jürgen Ligthart, Patrick W. Serruys, Robert‐Jan van Geuns

EuroIntervention

Article2015

TCT-507 Edge Vascular Response After Resorption of Everolimus-Eluting Bioresorbable Vascular Scaffold: A 5-Year Serial Optical Coherence Tomography Study

Hiroki Tateishi, Shimpei Nakatani, Yuki Ishibashi, Pannipa Suwannasom, Maik J. Grundeken, Yohei Sotomi, Yaping Zeng, Erhan Tenekecioğlu, Susan Veldhof, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2011

ANGIOGRAPHIC MAXIMAL LUMINAL DIAMETER AND APPROPRIATE DEPLOYMENT OF THE EVEROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD AS ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY

Josep Gómez‐Lara, Roberto Diletti, Salvatore Brugaletta, Yoshinobu Onuma, Leif Thuesen, Dougal McClean, Jacques Koolen, Héctor M. García‐García, Patrick W. Serruys

Journal of the American College of Cardiology

Article2015

Early and late optical coherence tomography findings following everolimus-eluting bioresorbable vascular scaffold implantation in myocardial infarction: a preliminary report.

Αντώνιος Καρανάσος, Takashi Muramatsu, Roberto Diletti, Sjoerd T. Nauta, Yoshinobu Onuma, Mattie Lenzen, Tomoya Nakatani, Nicolas M. Van Mieghem, Carl Schultz, Peter de Jaegere, Patrick W. Serruys, Felix Zijlstra, E. Regar, Robert‐Jan van Geuns

PubMed

Article2014

TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold

Bernard De Bruyne, Gábor G. Tóth, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Five-Year Optical Coherence Tomography Follow-Up of an Everolimus-Eluting Bioresorbable Vascular Scaffold

Abstract

Discussion(0)

Related publications

Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment

TCT-507 Edge Vascular Response After Resorption of Everolimus-Eluting Bioresorbable Vascular Scaffold: A 5-Year Serial Optical Coherence Tomography Study

ANGIOGRAPHIC MAXIMAL LUMINAL DIAMETER AND APPROPRIATE DEPLOYMENT OF THE EVEROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD AS ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY

Early and late optical coherence tomography findings following everolimus-eluting bioresorbable vascular scaffold implantation in myocardial infarction: a preliminary report.

TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold